Skip to main content
. 2020 Dec 3;8:601953. doi: 10.3389/fcell.2020.601953

FIGURE 9.

FIGURE 9

SIRT2 and TFEB are down-regulated in human NSCLC tissues and positively correlated with overall survival in TCGA database. (A,B) The expression of SIRT2 in lung adenocarcinoma (LUAD) patients (t = 483, n = 347) and the overall survival (OS) curves of SIRT2high (n = 239) and SIRT2low (n = 239) NSCLC patients. (C) Total protein was extracted from human NSCLC tissues (n = 40), SIRT2 was detected by western blot, the upper panel shows SIRT2 expression in four tumor tissues samples with corresponding normal lung tissues samples. And the lower panel indicates the quantification of SIRT2 protein level in NSCLC tissues and corresponding normal lung tissues (n = 40, ****P < 0.0001). (D,E) The expression of TFEB in LUAD patients (t = 483, n = 347) and the OS curves of TFEBhigh (n = 239) and TFEBlow (n = 239) NSCLC patients. (F) The expression of TFEB was detected in human NSCLC tissues, the upper panel shows the expression of TFEB in four tumor tissues samples with corresponding normal lung tissues samples. And the lower panel indicates the quantification of SIRT2 protein level in NSCLC tissues and corresponding normal lung tissues (n = 40, ***P < 0.001). (G,H) IHC staining detected the expression of SIRT2 and TFEB in human NSCLC tissues (n = 40, **P < 0.01).